ÂÜÀòÂÒÂ×

Qunwei Wang is an experienced scientist specializing in genomic recombineering and novel therapeutics discovery. Currently serving as the Group Lead for the Discovery pipeline at T-Therapeutics Ltd since January 2023, Qunwei previously held the position of Staff Scientist at the University of Cambridge from November 2018 to October 2023. Prior roles include Staff Scientist at the Wellcome Sanger Institute, Research Leader/Project Manager at Anhui Sinobioway Groups in China, Research Scientist at SCANCELL LIMITED, and Postdoctoral Research Fellow at the University of Nottingham. Academic achievements include a PhD in Oncology and a Master’s degree in Cancer Immunology from the University of Nottingham, as well as a Bachelor’s degree in Pharmacology from the University of Portsmouth.